Quarterly Dose - April 2012

Review past articles from the Quarterly Dose.

Letter from the Director: April 2012

April 25, 2012 by CWW Staff

CWW's new Director, Dr. David Addiss, introduces us to this month's issue of the Quarterly Dose and the exciting future of STH control. In it, we explore the changing world of STH control; CWW announces its partnership with GlaxoSmithKline; we introduce new leadership and learn about opportunities for the STH Advisory Committee; we discuss ways to engage the education sector in STH control; and we learn about CWW's work with Bolivia to pilot a deworming program.

Click the Read More link below to read the complete Letter from the Director.

In: April 2012 

Read more  Comments (0)

GSK and CWW Partnership Announcement

April 25, 2012 by CWW Staff

Children Without Worms (CWW) and GlaxoSmithKline (GSK) recently announced their formal partnership. Now, with commitments for donations from GSK and CWW founder Johnson & Johnson, a combined 600 million doses of deworming medications will be available each year to treat school-age children around the world who are at risk for soil-transmitted helminth (STH) infection. Plus, at the London Declaration on NTDs in late January, both companies pledged to extend these commitments through 2020.

In: April 2012 

Read more  Comments (0)

Engaging the Education Sector in STH Control

April 25, 2012 by CWW Staff

Kim Koporc at Joint Task Force Meeting Lao PDRHealth programs aimed at children are increasingly relying on the infrastructure and personnel at schools to carry out simple health interventions like deworming and hygiene education. This makes sense because teachers are often the most informed people to determine the best time of year to carry out mass drug administration campaigns and the types of messages that resound with students of various ages. At CWW, we recognize the enormous contributions the education sector can make to STH control efforts. For this reason, we examine ways to collaborate and strengthen partnerships with Ministries of Education and their equivalents in our program countries. CWW has additional plans for building bridges with the education sector in the coming years.

In: April 2012 

Read more  Comments (0)

Bolivia Launches Pilot Program for Deworming

April 25, 2012 by CWW Staff

SEDES Health Personnel Bolivia In 2011, Izumi Foundation awarded CWW a grant to help Bolivia's Ministry of Health and Sport (MSyD) develop and implement an STH control pilot project. The Pan American Health Organization (PAHO) was asked to participate in the project due to their success with a similar project done in 2008 to address fasciola infection. The STH control project, designed around the assumption that infection rates strongly relate to the ecological conditions of an area, will start by mapping "ecoregions." Then they will use the approach used by the fasciola project to demonstrate proof of concept in three different communities. Ultimately, the success of the project could lead to a longer-term commitment to STH control in Bolivia.

In: April 2012 

Read more  Comments (1)

New Leadership and Opportunities for CWW

April 25, 2012 by CWW Staff

STH Advisory Committee Leadership ChangeThis past October, the STH Advisory Committee, formerly the Mebendazole Advisory Committee, convened its 7th annual  meeting in Geneva. The meeting provided an opportunity for CWW and its partners in STH control to come together to focus on several important goals. First, to develop strategies that will enable countries to successfully use the combined 600 million doses of deworming drugs that Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) will donate annually. Second, to explore CWW’s role in supporting a comprehensive control strategy for STH through engagement with the water, sanitation and hygiene (WASH) and education sectors. A highlight at the meeting’s close was recognition of the accomplishments of outgoing committee chair Mr. Ibrahim Jabr, and welcoming of incoming chair Dr. Susan Zimicki.

In: April 2012 

Read more  Comments (0)